11/19/2024
8:57 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
5:51 AM | Akero Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/13/2024
8:45 AM | Akero Therapeutics (Subject)
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
4:06 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
9:52 AM | Akero Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/08/2024
6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
6:19 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/06/2024
4:01 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024
8:00 AM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
8:04 AM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
7:59 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:46 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
7:57 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
10:13 AM | Akero Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/16/2024
7:06 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
7:06 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:50 PM | Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
3:38 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
7:04 AM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
7:09 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:03 PM | Akero Therapeutics (Subject)
Young Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/23/2024
5:00 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
8:19 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:34 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
4:14 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:16 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:10 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:11 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:13 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:09 AM | Akero Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
09/05/2024
3:05 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:08 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:30 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
10:11 AM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:32 PM | Akero Therapeutics (Subject)
White William Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
3:27 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
10:45 AM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
6:15 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2024
8:32 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
4:54 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin |
07/24/2024
3:25 PM | Akero Therapeutics (Subject)
White William Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024
8:41 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:55 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:55 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:56 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:56 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:57 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:01 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:04 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:06 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:09 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:11 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:13 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
4:23 PM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
4:20 PM | Akero Therapeutics (Issuer)
Judy Chou (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:22 PM | Akero Therapeutics (Issuer)
Harrison Seth Loring (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:24 PM | Akero Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:25 PM | Akero Therapeutics (Issuer)
Heyman Tomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:28 PM | Akero Therapeutics (Issuer)
Iwicki Mark T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:29 PM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:31 PM | Akero Therapeutics (Issuer)
Xu Yuan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:17 PM | Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
06/05/2024
4:05 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
6:17 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
8:07 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:32 PM | Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2024
6:36 PM | Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:30 PM | Akero Therapeutics (Filer)
| Form PRE 14A | |
04/03/2024
5:55 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:17 PM | Akero Therapeutics (Subject)
Young Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
3:31 PM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:42 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:42 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:43 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:44 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:45 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
9:08 AM | Akero Therapeutics (Subject)
GENERAL ATLANTIC, L.P. (Filed by)
| Form SC 13G | |
03/06/2024
7:13 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:14 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:25 PM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:16 PM | Akero Therapeutics (Filer)
| Form 424B5 | |
03/05/2024
4:16 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:30 PM | Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
6:55 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:42 PM | Akero Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024
6:30 AM | Akero Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
6:15 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:19 PM | Akero Therapeutics (Subject)
PFIZER INC (Filed by)
| Form SC 13G/A | |
02/14/2024
6:06 AM | Akero Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you.
A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide |
02/13/2024
8:40 PM | Akero Therapeutics (Subject)
Avidity Partners Management LP (Filed by)
| Form SC 13G/A | |
02/13/2024
5:30 PM | Akero Therapeutics (Subject)
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
10:31 AM | Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/07/2024
6:23 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Akero Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024
8:36 AM | Akero Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/29/2023
7:30 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
5:07 PM | Akero Therapeutics (Subject)
Young Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
7:49 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:37 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
